Working… Menu

Ibrutinib and Rituximab Compared With Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02048813
Recruitment Status : Active, not recruiting
First Posted : January 29, 2014
Last Update Posted : September 28, 2021
Information provided by (Responsible Party):
National Cancer Institute (NCI)